Based on their predicted binding motifs encompassing the transcriptional start site of ZNF582-AS1, we speculate that ZNF582-AS1 expression may be downregulated in breast cancer by these transcription factors [50,51,52]. The gene discussed is ZNF582; the disease is breast carcinoma.